title: [Clinical analysis of male urethritis].
abstract: We reviewed 497 patients with male urethritis diagnosed between January, 1986 and March, 1989 at the Asama General Hospital. The incidence of gonococcal urethritis (GU) was 47.7%, and that of non-gonococcal urethritis (NGU) 52.3%. There was no difference in the age distribution between GU and NGU. Prostitutes were the most common source of the infection in both GU and NGU. Incubation periods were longer in NGU than in GU, statistically. Urethral discharge was the most common symptom. Purulent urethral discharge was seen more commonly than serous urethral discharge in GU. On the contrary, serous urethral discharge was more common in NGU. Penicillin-resistant gonococcus comprised 29.4% and mixed infection of the C. trachomatis existed 25.6% in GU. C. trachomatis was detected in 71.8% in NGU. In GU, new quinolones and penicillins were administered frequently. The effective rates 1 week after the administration were 80.6% and 83.3%, respectively. In NGU, new quinolones and minocycline were administered frequently. The effective rates were 70.4% and 85.3%, respectively. Ofloxacin (OFLX) showed the highest effective rate to NGU among the four new quinolones. The relapse rate for the two-week administration group was lower than that for the one-week-administration group, but the difference was not statistically significant.
authors.affiliation: Department of Urology, Asama General Hospital.
authors.forename: S
authors.initials: S
authors.lastname: Nakata
authors.forename: M
authors.initials: M
authors.lastname: Miki
authors.forename: K
authors.initials: K
authors.lastname: Okabe
authors.forename: T
authors.initials: T
authors.lastname: Mashimo
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Yamanaka
authors.forename: O
authors.initials: O
authors.lastname: Takahashi
authors.forename: T
authors.initials: T
authors.lastname: Onuki
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008219:Lymphogranuloma Venereum / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use; D015242:Ofloxacin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D012189:Retrospective Studies; D012749:Sexually Transmitted Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D014526:Urethritis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
chemical_list: D010406:Penicillins; D015363:Quinolones; D015242:Ofloxacin; D008911:Minocycline